Saturday 17 October 2026
Export HIND’s income statement to Excel — free account
Vyome Holdings, Inc.
HIND Healthcare Biotechnology
In the quarter to June 2026, revenue fell 46.0%, EPS grew 100.0% and free cash flow fell 195.0%, each against the same quarter a year earlier.
1.87
0.04
−2.09%
Follow HIND
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 2 | 5 | — | — | 5 | 5 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
99,162,871.79 | 104,890,153.82 | 3,767,622.90 | 2,371,432.79 | 451,015.58 | 0.00 | 0.81 | 0.18 | 0.35 | 23.25 |
Altman Z-Score |
13,476,384.94 | 32,066,190.82 | 1,190,653.79 | 1,027,362.74 | 135,434.19 | — | (90.57) | (86.44) | (63.09) | (22.00) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
5.95 | (3.98) | (20.87) | (26.97) | (47.34) | (34.80) | (208.64) | (198.25) | (162.29) | (50.57) |
P/Operating CF |
(58,261,406.75) | (113,067,411.66) | (6,332,250.42) | (1,594,726.58) | (2,892,182.18) | 0.00 | (3.21) | (0.63) | (30.76) | (5.03) |
Beneish M-Score |
(2.18) | (0.02) | (4.60) | (1.68) | 4.01 | (6.74) | (14.50) | (0.23) | 17.90 | — |
P/B ratio |
5,232,246.70 | 29,615,270.27 | 2,616,093.39 | 490,925.04 | 351,765.38 | 0.00 | 2.48 | 0.23 | 0.00 | 1.98 |
Price to Tangible BV |
5,232,246.70 | 29,615,270.27 | 2,616,093.39 | 490,925.04 | 0.00 | 0.00 | 2.67 | 0.24 | 0.00 | 2.16 |
EV/Sales |
99,162,853.42 | 104,890,150.35 | 3,767,622.41 | 2,371,428.85 | 451,016.44 | (0.98) | 1.29 | 0.72 | 49.61 | 47.56 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(17,371,931.11) | (33,956,405.12) | (1,165,028.93) | (340,271.94) | (596,027.46) | 0.87 | (0.66) | (0.37) | (20.75) | (4.06) |
EV/FCF |
(17,061,843.90) | (32,838,000.14) | (1,116,400.72) | (337,409.28) | (570,026.26) | 0.85 | (0.66) | (0.37) | (20.76) | (4.06) |
Quick Ratio |
16.55 | 4.86 | 1.43 | 3.61 | 0.48 | 3.40 | 0.82 | 1.65 | 0.19 | 1.82 |
Current Ratio |
17.00 | 5.17 | 1.66 | 4.59 | 0.77 | 3.98 | 1.32 | 2.73 | 0.05 | 1.99 |
Net Debt/EBITDA |
3.43 | 1.01 | 0.38 | 0.58 | (1.07) | 0.41 | 0.09 | 0.30 | (3.53) | 0.48 |
Debt/Assets |
12.54% | 18.69% | 32.68% | 5.53% | 34.48% | 0.53% | 1.53% | 0.00% | 259.80% | 0.00% |
Debt/Equity |
0.15 | 0.28 | 0.76 | 0.07 | 0.88 | 0.01 | 0.05 | 0.00 | (0.82) | 0.00 |
Asset Turnover |
0.07 | 0.15 | 0.22 | 0.13 | 0.39 | 0.30 | 0.35 | 0.80 | 0.04 | 0.08 |
Operating CF/Net income |
0.95 | 0.88 | 0.79 | 0.97 | 0.40 | 0.24 | 0.47 | 1.49 | 0.42 | 0.37 |
Capex/Depreciation |
(0.91) | (2.67) | (2.26) | (0.20) | (0.12) | (0.14) | (0.04) | (0.06) | 0.02 | 0.00 |
Interest Coverage |
(40.89) | (254.75) | (163.56) | (60.34) | (6.08) | (69.57) | (410.19) | 591.65 | (4.88) | (71.30) |
| (446.59%) | (69.94%) | (155.04%) | (163.53%) | (142.60%) | (214.71%) | (192.58%) | (220.59%) | (127.42%) | 3,262.96% | |
| (44.02%) | (52.72%) | (89.55%) | (93.25%) | (75.30%) | (140.96%) | (145.16%) | (104.44%) | (24.04%) | (260.50%) | |
ROIC |
0.00% | (3,384.94%) | 0.00% | (496.88%) | (32.10%) | (165.96%) | 0.00% | (456.96%) | 0.00% | 0.00% |
Return on Tangible Assets |
(27.59%) | (80.68%) | (284.15%) | (154.35%) | 1,041.41% | (264.63%) | (1,477.43%) | (173.08%) | 26.91% | (373.23%) |
Average Days of Receivables |
55.40 | 155.48 | 34.89 | 31.71 | 84.64 | 75.55 | 70.79 | 69.78 | 1,402.32 | 0.00 |
Research and Development Expense of Revenue |
290.95% | 107.39% | 117.54% | 210.09% | 30.96% | 17.42% | 22.57% | 26.68% | 111.09% | 184.02% |
Selling, General and Administrative Expense of Revenue |
301.12% | 290.79% | 329.04% | 508.02% | 134.71% | 244.21% | 278.85% | 205.95% | 349.79% | 739.94% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.73 | 0.40 | 0.02 | 0.00 | 0.23 | 0.05 |
Share Based Compensation of Revenue |
16.59% | 32.69% | 51.57% | 90.92% | 11.71% | 89.90% | 18.57% | 8.83% | 71.62% | 2,057.18% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 4.07 | (61.33) | 0.36 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34,650.37 | 0.00 |
Earnings Yield |
(5.58%) | 0.00% | (18.89%) | (33.77%) | (11.36%) | (152.20%) | (695.38%) | (718.88%) | (544.96%) | (141.04%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (242.15%) | (1,095.83%) | (688.12%) | (50.43%) |
Revenue per Share |
0.80 | 0.59 | 4.78 | 0.70 | 2.89 | 0.00 | 112,400.00 | 8,678.00 | 1,284.50 | 0.15 |
Operating CF per Share |
(4.59) | (1.83) | (15.46) | (4.86) | (2.19) | 0.00 | (219,020.00) | (16,960.00) | (3,070.50) | (1.73) |
Capex per Share |
(0.08) | (0.06) | (0.67) | (0.04) | (0.10) | 0.00 | (920.00) | (10.00) | 1.50 | 0.00 |
Free Cash Flow per Share |
(4.67) | (1.89) | (16.13) | (4.90) | (2.29) | 0.00 | (219,940.00) | (16,970.00) | (3,069.00) | (1.73) |
Cash per Share |
17.88 | 2.66 | 12.47 | 2.99 | 0.77 | 0.00 | 39,550.00 | 4,559.00 | 509.50 | 2.31 |
Shareholders Equity per Share |
15.23 | 2.10 | 6.88 | 3.37 | 3.71 | 0.00 | 36,610.00 | 6,663.00 | (21,955.00) | 1.74 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
Book value per Share |
15.23 | 2.10 | 6.88 | 3.37 | 3.71 | 0.00 | 36,610.00 | 6,663.00 | (21,955.00) | 1.74 |
Free Cash Flow |
(19.72) | (31.67) | (30.71) | (23.06) | (8.94) | (15.73) | (21.99) | (16.97) | (0.61) | (3.75) |
Working Capital |
73.47 | 41.74 | 11.42 | 14.26 | (2.66) | 22.41 | 2.43 | 6.52 | (5.44) | 2.70 |
Capital Expenditures |
(0.35) | (1.04) | (1.28) | (0.19) | (0.39) | (0.35) | (0.09) | (0.01) | 0.00 | — |
Net Current Asset Value |
63.59 | 33.77 | 11.37 | 13.69 | (13.63) | 21.74 | 2.43 | 6.30 | (5.47) | 2.70 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.10 | 0.11 | 0.14 | 0.06 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 0.29 | 0.33 | 0.89 | 5.76 | 1.70 | 3.08 | 2.57 | 0.29 | 0.26 |
Cash ROIC |
(13.18%) | (35.41%) | (65.67%) | (74.31%) | (29.53%) | (23.32%) | (282.45%) | (151.22%) | 87.72% | (42.87%) |
Accounts Receivable Turnover |
5.90 | 4.18 | 3.57 | 5.68 | 7.78 | 5.00 | 4.50 | 4.52 | 0.19 | 0.00 |
Accounts Payable Turnover |
4.91 | 5.16 | 4.45 | 3.27 | 2.34 | 1.47 | 1.65 | 1.73 | 0.05 | 0.09 |
Inventory Turnover |
4.72 | 4.30 | 3.62 | 1.68 | 2.41 | 2.00 | 1.34 | 0.85 | 0.02 | 0.00 |
Average Days of Payables |
77.31 | 96.45 | 78.01 | 80.18 | 264.86 | 241.02 | 158.40 | 196.96 | 5,684.58 | 4,654.56 |
Days of Inventory on Hand |
107.46 | 107.18 | 106.34 | 239.54 | 162.61 | 208.70 | 296.98 | 436.25 | 14,482.26 | 0.00 |
Average Receivables |
0.58 | 2.37 | 2.55 | 0.58 | 1.45 | 2.72 | 2.50 | 1.92 | 1.32 | — |
Average Payables |
0.57 | 0.94 | 1.22 | 0.90 | 2.15 | 3.56 | 2.70 | 1.81 | 1.33 | 1.13 |
Average Inventory |
0.60 | 1.12 | 1.50 | 1.76 | 2.09 | 2.62 | 3.31 | 3.68 | 3.10 | — |
Average Assets |
46.50 | 65.94 | 41.74 | 25.39 | 28.73 | 44.80 | 31.84 | 10.90 | 6.02 | 3.94 |
Average Common Equity |
4.58 | 49.71 | 24.11 | 14.48 | 15.17 | 29.41 | 24.00 | 5.16 | 1.14 | (0.31) |
Columns are period end dates · fundamentals updated 1 Oct 2026